Eversept Partners, LP Buys Laboratory Corp of America Holdings, Ascendis Pharma A/S, Community Health Systems Inc, Sells Qiagen NV, Amarin Corp PLC, Organon

Investment company

Eversept Partners, LP (Current Portfolio) buys Laboratory Corp of America Holdings, Ascendis Pharma A/S, Community Health Systems Inc, Catalent Inc, Icon PLC, sells Qiagen NV, Amarin Corp PLC, Organon, Danaher Corp, Omnicell Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Eversept Partners, LP. As of 2021Q3, Eversept Partners, LP owns 100 stocks with a total value of $1.3 billion. These are the details of the buys and sells.

• New Purchases: LH, CTLT, ICLR, MASI, SNY, NSTG, PKI, IRTC, HRC, SIBN, EVH, KRTX, PBYI, VRDN, MORF, ADAP, MREO, ANAB, AVRO, MYO, GOSS, ARGX, MRTX, LOGC, ACIU, MGTA, ORTX, AKYA, CYCN, ASMB, PHAS, ELDN, MIST, FREQ,
• Added Positions: ASND, CYH, MCK, AVTR, MRVI, GH, NTRA, GSK, ANTM, HCA, EXEL, AMRX, NVST, GOCO, CNC, ZGNX, ITCI, LXRX, XLRN, HUM, ALNY, A, ISRG, IONS, IQV, HSKA, TARO, RGEN, ENSG,
• Reduced Positions: QGEN, AMRN, DHR, AMN, OCDX, ARKG, FATE, HQY, ARKK, AZN, HZNP, OM, TEVA, DXCM, BMY, TLGTQ, AUTL, SRGA, FSTX, CCRN, LQDA,
• Sold Out: OGN, OMCL, VRTX, CI, OPCH, AFMD, CGEM, KDMN, XENT, IPSC, TGTX, OCUL, AHAC, MCRB, IMVT,

For the details of Eversept Partners, LP's stock buys and sells, go to https://www.gurufocus.com/guru/eversept+partners%2C+lp/current-portfolio/portfolio

These are the top 5 holdings of Eversept Partners, LP

1. United Therapeutics Corp (UTHR) - 444,471 shares, 6.24% of the total portfolio. Shares added by 0.34%
2. Ascendis Pharma A/S (ASND) - 445,203 shares, 5.39% of the total portfolio. Shares added by 84.14%
3. Community Health Systems Inc (CYH) - 5,988,163 shares, 5.33% of the total portfolio. Shares added by 56.69%
4. Horizon Therapeutics PLC (HZNP) - 634,670 shares, 5.28% of the total portfolio. Shares reduced by 4.81%
5. Acceleron Pharma Inc (XLRN) - 349,494 shares, 4.57% of the total portfolio. Shares added by 4.31%

New Purchase: Laboratory Corp of America Holdings (LH)

Eversept Partners, LP initiated holding in Laboratory Corp of America Holdings. The purchase prices were between $274.82 and $308.34, with an estimated average price of $293.32. The stock is now traded at around $286.920000. The impact to a portfolio due to this purchase was 2.74%. The holding were 128,311 shares as of 2021-09-30.

New Purchase: Catalent Inc (CTLT)

Eversept Partners, LP initiated holding in Catalent Inc. The purchase prices were between $109.17 and $142.35, with an estimated average price of $124.9. The stock is now traded at around $128.500000. The impact to a portfolio due to this purchase was 1.86%. The holding were 184,299 shares as of 2021-09-30.

New Purchase: Icon PLC (ICLR)

Eversept Partners, LP initiated holding in Icon PLC. The purchase prices were between $208.53 and $283.04, with an estimated average price of $242.91. The stock is now traded at around $282.940000. The impact to a portfolio due to this purchase was 1.43%. The holding were 71,911 shares as of 2021-09-30.

New Purchase: Masimo Corp (MASI)

Eversept Partners, LP initiated holding in Masimo Corp. The purchase prices were between $249 and $285.24, with an estimated average price of $270.95. The stock is now traded at around $298.580000. The impact to a portfolio due to this purchase was 1.38%. The holding were 67,000 shares as of 2021-09-30.

New Purchase: Sanofi SA (SNY)

Eversept Partners, LP initiated holding in Sanofi SA. The purchase prices were between $47.89 and $53.12, with an estimated average price of $50.89. The stock is now traded at around $51.160000. The impact to a portfolio due to this purchase was 0.95%. The holding were 259,128 shares as of 2021-09-30.

New Purchase: PerkinElmer Inc (PKI)

Eversept Partners, LP initiated holding in PerkinElmer Inc. The purchase prices were between $151.98 and $190.5, with an estimated average price of $176.11. The stock is now traded at around $183.640000. The impact to a portfolio due to this purchase was 0.62%. The holding were 47,081 shares as of 2021-09-30.

Added: Ascendis Pharma A/S (ASND)

Eversept Partners, LP added to a holding in Ascendis Pharma A/S by 84.14%. The purchase prices were between $112.67 and $176.92, with an estimated average price of $137.27. The stock is now traded at around $151.885000. The impact to a portfolio due to this purchase was 2.46%. The holding were 445,203 shares as of 2021-09-30.

Added: Community Health Systems Inc (CYH)

Eversept Partners, LP added to a holding in Community Health Systems Inc by 56.69%. The purchase prices were between $10.8 and $16.09, with an estimated average price of $13.08. The stock is now traded at around $14.790000. The impact to a portfolio due to this purchase was 1.93%. The holding were 5,988,163 shares as of 2021-09-30.

Added: McKesson Corp (MCK)

Eversept Partners, LP added to a holding in McKesson Corp by 115.61%. The purchase prices were between $188.42 and $208.66, with an estimated average price of $199.89. The stock is now traded at around $222.930000. The impact to a portfolio due to this purchase was 1.31%. The holding were 161,708 shares as of 2021-09-30.

Added: Avantor Inc (AVTR)

Eversept Partners, LP added to a holding in Avantor Inc by 32.56%. The purchase prices were between $35.36 and $44.01, with an estimated average price of $39.04. The stock is now traded at around $38.790000. The impact to a portfolio due to this purchase was 0.99%. The holding were 1,292,014 shares as of 2021-09-30.

Added: Maravai LifeSciences Holdings Inc (MRVI)

Eversept Partners, LP added to a holding in Maravai LifeSciences Holdings Inc by 337.08%. The purchase prices were between $36.8 and $60.62, with an estimated average price of $48.78. The stock is now traded at around $37.270000. The impact to a portfolio due to this purchase was 0.94%. The holding were 327,810 shares as of 2021-09-30.

Added: Guardant Health Inc (GH)

Eversept Partners, LP added to a holding in Guardant Health Inc by 5447.87%. The purchase prices were between $98.77 and $132.17, with an estimated average price of $119.09. The stock is now traded at around $102.025000. The impact to a portfolio due to this purchase was 0.93%. The holding were 100,361 shares as of 2021-09-30.

Sold Out: Organon & Co (OGN)

Eversept Partners, LP sold out a holding in Organon & Co. The sale prices were between $28.63 and $35.64, with an estimated average price of $32.03.

Sold Out: Omnicell Inc (OMCL)

Eversept Partners, LP sold out a holding in Omnicell Inc. The sale prices were between $141.84 and $160.88, with an estimated average price of $153.23.

Sold Out: Vertex Pharmaceuticals Inc (VRTX)

Eversept Partners, LP sold out a holding in Vertex Pharmaceuticals Inc. The sale prices were between $181.39 and $202.99, with an estimated average price of $195.37.

Sold Out: Cigna Corp (CI)

Eversept Partners, LP sold out a holding in Cigna Corp. The sale prices were between $200.16 and $238.3, with an estimated average price of $217.75.

Sold Out: Option Care Health Inc (OPCH)

Eversept Partners, LP sold out a holding in Option Care Health Inc. The sale prices were between $19.98 and $28.17, with an estimated average price of $23.25.

Sold Out: Affimed NV (AFMD)

Eversept Partners, LP sold out a holding in Affimed NV. The sale prices were between $5.54 and $7.51, with an estimated average price of $6.59.

Here is the complete portfolio of Eversept Partners, LP. Also check out:

1. Eversept Partners, LP's Undervalued Stocks
2. Eversept Partners, LP's Top Growth Companies, and
3. Eversept Partners, LP's High Yield stocks
4. Stocks that Eversept Partners, LP keeps buying